The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen
Abstract
ChimeriVax-JE is a live, attenuated vaccine against Japanese encephalitis, using yellow fever (YF) 17D vaccine as a vector. In a double-blind phase 2 trial, 99 adults received vaccine, placebo, or YF 17D vaccine (YF-VAX). ChimeriVax-JE was well tolerated, with no differences in adverse events between treatment groups. Viremias resulting from administration of ChimeriVax-JE and YF-VAX were of short duration and low titer; 82 (94%) of 87 subjects administered graded doses (1.8-5.8 log(10)) of ChimeriVax-JE developed neutralizing antibodies. A second dose, administered 30 days later, had no booster effect. Previous inoculation with YF did not interfere with ChimeriVax-JE, but there was a suggestion (not statistically significant) that ChimeriVax-JE interfered with YF-VAX administered 30 days later. A separate study explored immunological memory both in subjects who had received ChimeriVax-JE 9 months before and in ChimeriVax-JE-naive subjects challenged with inactivated mouse-brain vaccine (JE-VAX). Anamnestic responses were observed in preimmune individuals. ChimeriVax-JE appears to be a safe vaccine that provides protective levels of neutralizing antibody after a single dose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LaFleur, C., Granados, J., Vargas-Alarcon, G., Ruíz-Morales, J., Villarreal-Garza, C., Higuera, L., Hernández-Pacheco, G., Cutiño-Moguel, T., Rangel, H., Figueroa, R., et al. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00682-1 · Cited by 103
Cited by
Factors That Influence the Immune Response to Vaccination
Zimmermann, P., & Curtis, N. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00084-18 · Cited by 939
Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., Akira, S., Ahmed, R., & Pulendran, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051720 · Cited by 552
Ecology and Geographical Expansion of Japanese Encephalitis Virus
van den Hurk, A. F., Ritchie, S. A., & Mackenzie, J. S. (2009) · Annual Review of Entomology · doi:10.1146/annurev.ento.54.110807.090510 · Cited by 496
Monath, T. P. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.4.553 · Cited by 467
Self-citationThe Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
Akondy, R. S., Monson, N. D., Miller, J. D., Edupuganti, S., Teuwen, D., Wu, H., Quyyumi, F., Garg, S., Altman, J. D., Del Rio, C., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803903 · Cited by 343
Prausnitz, M. R., Mikszta, J. A., Cormier, M., & Andrianov, A. K. (2009) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-92165-3_18 · Cited by 314
Guy, B., Guirakhoo, F., Barban, V., Higgs, S., Monath, T. P., & Lang, J. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.09.098 · Cited by 291
Self-citationJapanese encephalitis: The virus and vaccines
Yun, S.-I., & Lee, Y.-M. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.26902 · Cited by 288
Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines
Barrett, P. N., Mundt, W., Kistner, O., & Howard, M. K. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.19 · Cited by 281
Japanese encephalitis vaccines
Halstead, S. B., & Jacobson, J. (2008) · Vaccines · doi:10.1016/b978-1-4160-3611-1.50021-0 · Cited by 264
Plotkin, S. A. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00290-09 · Cited by 256
Guirakhoo, F., Pugachev, K., Zhang, Z., Myers, G., Levenbook, I., Draper, K., Lang, J., Ocran, S., Mitchell, F., Parsons, M., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4761-4775.2004 · Cited by 253
Self-citationMimicking live flavivirus immunization with a noninfectious RNA vaccine
Kofler, R. M., Aberle, J. H., Aberle, S. W., Allison, S. L., Heinz, F. X., & Mandl, C. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307145101 · Cited by 116
Schulz, A. R., Mälzer, J. N., Domingo, C., Jürchott, K., Grützkau, A., Babel, N., Nienen, M., Jelinek, T., Niedrig, M., & Thiel, A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500598 · Cited by 112
Rise of the RNA machines – self-amplification in mRNA vaccine design
Comes, J. D. G., Pijlman, G. P., & Hick, T. A. H. (2023) · Trends in Biotechnology · doi:10.1016/j.tibtech.2023.05.007 · Cited by 87
Metadata
- Authors
- Monath, T. P., Guirakhoo, F., Nichols, R., Yoksan, S., Schrader, R., Murphy, C., Blum, P., Woodward, S., McCarthy, K., Mathis, D., Johnson, C., & Bedford, P.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-10-15
- Volume
- 188
- Issue
- 8
- Pages
- 1213-1230
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2140048277
- Cited by
- 218
- References
- 1
- FWCI
- 12.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.